Evidence map›Paper›PMID 39406515›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2024

The Alzheimer's Disease Risk Gene CD2AP Functions in Dendritic Spines by Remodeling F-Actin.

Farzaneh S Mirfakhar, Jorge Castanheira, Raquel Domingues, José S Ramalho, Cláudia Guimas Almeida

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. A New Molecular Mechanism for the Late-Onset Alzheimer's Disease Risk Gene CD2AP.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Farzaneh S MirfakhariNOVA4Health, NOVA Medical School, Universidade Nova de Lisboa, Lisboa 1169-056, Portugal.ORCID 0000-0002-8392-7244
Jorge CastanheiraiNOVA4Health, NOVA Medical School, Universidade Nova de Lisboa, Lisboa 1169-056, Portugal.ORCID 0000-0003-2307-7206
Raquel DominguesiNOVA4Health, NOVA Medical School, Universidade Nova de Lisboa, Lisboa 1169-056, Portugal.ORCID 0000-0003-1413-6956
José S RamalhoiNOVA4Health, NOVA Medical School, Universidade Nova de Lisboa, Lisboa 1169-056, Portugal.ORCID 0000-0002-1927-164X
Cláudia Guimas AlmeidaiNOVA4Health, NOVA Medical School, Universidade Nova de Lisboa, Lisboa 1169-056, Portugal claudia.almeida@nms.unl.pt.ORCID 0000-0001-9384-2896

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD2-associated protein (CD2AP) was identified as a genetic risk factor for late-onset Alzheimer's disease (LOAD). However, it is unclear how CD2AP contributes to LOAD synaptic dysfunction underlying AD memory deficits. We have shown that loss of CD2AP function increases β-amyloid (Aβ) endocytic production, but it is unknown whether it contributes to synapse dysfunction. As CD2AP is an actin-binding protein, it may also function in F-actin-rich dendritic spines, which are the excitatory postsynaptic compartments. Here, we demonstrate that CD2AP colocalizes with F-actin in dendritic spines of primary mouse cortical neurons of both sexes. Cell-autonomous depletion of CD2AP specifically reduces spine density and volume, resulting in a functional decrease in synapse formation and neuronal network activity. Postsynaptic reexpression of CD2AP, but not blocking Aβ production, is sufficient to rescue spine density. CD2AP overexpression increases spine density, volume, and synapse formation, while a rare LOAD CD2AP mutation induces aberrant F-actin spine-like protrusions without functional synapses. CD2AP controls postsynaptic actin turnover, with the LOAD mutation in CD2AP decreasing F-actin dynamicity. Our data support that CD2AP risk variants could contribute to LOAD synapse dysfunction by disrupting spine formation and growth by deregulating actin dynamics.

Indexed as

ActinsAdaptor Proteins, Signal TransducingAlzheimer DiseaseCytoskeletal ProteinsDendritic SpinesAnimalsCells, CulturedFemaleHumansMaleMiceMice, Inbred C57BLNeuronsSynapsesActinsAdaptor Proteins, Signal TransducingCD2-associated proteinCytoskeletal ProteinsAlzheimer’s diseaseCD2APdendritic spinesneuronrisk factorspinal F-actin

Identifiers

PMID39406515
PMCPMC11604147

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.